drugset / Trial / NCT01167101

Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection?

NCT01167101

Completed 290 enrolled Kangdong Sacred Heart Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

Treatment strategy of post endoscopic submucosal dissection (ESD) ulcer is not yet conclusive. Rebamipide is a mucosal protective agent widely used in East Asia and has good effect on quality of ulcer healing (QOUH). The investigators will conduct this randomized controlled study to assess the effect of a combination therapy of rebamipide and proton pump inhibitor (PPI) on post ESD ulcer healing.

Timeline

Start
2009-05
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rebamipide Small molecule 100 mg
Background Pantoprazole Other / unclassified 40 mg

Indications